The effect of chronic renal failure on drug metabolism and transport
- PMID: 18680441
- PMCID: PMC2745294
- DOI: 10.1517/17425255.4.8.1065
The effect of chronic renal failure on drug metabolism and transport
Abstract
Background: Chronic renal failure (CRF) has been shown to significantly reduce the nonrenal clearance and alter bioavailability of drugs predominantly metabolized by the liver and intestine.
Objectives: The purpose of this article is to review all significant animal and clinical studies dealing with the effect of CRF on drug metabolism and transport.
Methods: A search of the National Library of Medicine PubMed was done with terms such as chronic renal failure, cytochrome P450 [CYP], liver metabolism, efflux drug transport and uptake transport, including relevant articles back to 1969.
Results: Animal studies in CRF have shown a significant downregulation (40-85%) of hepatic and intestinal CYP metabolism. High levels of parathyroid hormone, cytokines and uremic toxins have been shown to reduce CYP activity. Phase II reactions and drug transporters such as P-glycoprotein and organic anion transporting polypeptide are also affected.
Conclusion: CRF alters intestinal, renal and hepatic drug metabolism and transport producing a clinically significant impact on drug disposition and increasing the risk for adverse drug reactions.
Conflict of interest statement
Figures
References
-
- Reidenberg MM. Chapter 3, Drug metabolism in uremia, in Renal function and drug action. Philadelphia: Saunders; 1971. pp. 19–32.
-
First Book to address the effect of renal failure on drug metabolism pathways
-
- Gibson TP. Renal disease and drug metabolism: an overview. Am J Kidney Dis. 1986;8(1):7–17. - PubMed
-
- Touchette MA, Slaughter RL. The effect of renal failure on hepatic drug clearance. DICP Ann Pharmacother. 1991;25:1214–24. - PubMed
-
- Elston AC, Bayliss MK, Park GR. Effect of renal failure on drug metabolism by the liver. Brit J Anaesth. 1993;71:282–290. - PubMed
-
- Talbert RL. Drug dosing in renal insufficiency. J Clin Pharmacol. 1994;34:99–110. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical